5 Firms Guide $2.1B Alkermes-Avadel Sleep Medicine Deal
By Al Barbarino · October 22, 2025, 3:42 PM EDT
Dublin-based Alkermes PLC has agreed to buy Avadel Pharmaceuticals PLC, a fellow Irish drugmaker focused on sleep medicine, in an all-cash deal valuing Avadel at about $2.1 billion, the companies said...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login